Invention Grant
- Patent Title: Pharmaceutical composition comprising refined Indigo naturalis extracts and the use thereof
-
Application No.: US16261773Application Date: 2019-01-30
-
Publication No.: US10525095B2Publication Date: 2020-01-07
- Inventor: Laurent Chantalat , Philippe Andres
- Applicant: Galderma S.A.
- Applicant Address: CH Cham
- Assignee: Galderma S.A.
- Current Assignee: Galderma S.A.
- Current Assignee Address: CH Cham
- Agency: Panitch Schwarze Belisario & Nadel LLP
- Priority: EP15163061 20150409
- Main IPC: A61K36/70
- IPC: A61K36/70 ; A61K36/19 ; A61K36/315 ; A61K36/48 ; A61K8/49 ; A61K8/97 ; A61K9/00 ; A61K9/06 ; A61K31/404 ; A61K31/519 ; A61Q19/08
Abstract:
A refined Indigo Naturalis extract or Indigo-producing plant extract containing at least 65% (w/w) an indirubin derivative based on total weight of active ingredients is described. Also described are a pharmaceutical composition containing the refined extract, and the use of the pharmaceutical composition for treating or alleviating a disease or condition.
Public/Granted literature
- US10555985B2 Pharmaceutical composition comprising refined Indigo naturalis extracts and the use thereof Public/Granted day:2020-02-11
Information query
